Human Subject Protection--Information for Institutional Review Boards, Clinical Investigators, and Sponsors; Rescission, Reissuance, and Development of FDA Guidance Documents

1 organizations filed 1 public comment on Human Subject Protection--Information for Institutional Review Boards, Clinical Investigators, and Sponsors; Rescission, Reissuance, and Development of FDA Guidance Documents, at the Food and Drug Administration. The comment window closed 4292d ago.

Commenters (1)

• Advanced Medical Technology Associationtrade assoc.

  1 filing · confidence 97%